DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
IMIGLITAZAR
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus
Peroxisome proliferator-activated receptor alpha agonist
IMIGLITAZAR
×
Maximum Phase:
3
First Approval:
None
UNII:
7244710F59
Molecule Type:
Small molecule
Molecular Formula:
C28H26N2O5
Molecular Weight:
470.53
AlogP:
6.01
PSA:
94.15
HBD:
1.0
HBA:
#RotB:
11.0
Source:
BLOOD CELLS, RED
3
Unknown
Investigational
Unknown
Unknown
Anemia, Sickle Cell; Cardiovascular Diseases; Anemia; beta-Thalassemia; Wounds and Injuries
Unknown
BLOOD CELLS, RED
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAGATOSE
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
TAGATOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
T7A20Y888Y
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.38
PSA:
118.22
HBD:
5.0
HBA:
#RotB:
5.0
Source:
UPROLESELAN
3
Small molecule
Investigational
Unknown
Unknown
Venous Thrombosis; Multiple Myeloma; Leukemia, Myeloid, Acute
Selectin E antagonist
UPROLESELAN
×
Maximum Phase:
3
First Approval:
None
UNII:
PE952ANF83
Molecule Type:
Small molecule
Molecular Formula:
C60H109N3O27
Molecular Weight:
1304.53
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GIREDESTRANT
3
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Estrogen receptor alpha degrader
GIREDESTRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H31F5N4O
Molecular Weight:
522.56
AlogP:
4.87
PSA:
54.53
HBD:
3.0
HBA:
#RotB:
9.0
Source:
CHLORHEXIDINE DIACETATE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CHLORHEXIDINE DIACETATE
×
Maximum Phase:
3
First Approval:
None
UNII:
5908ZUF22Y
Molecule Type:
Small molecule
Molecular Formula:
C26H38Cl2N10O4
Molecular Weight:
625.56
AlogP:
4.18
PSA:
167.58
HBD:
10.0
HBA:
#RotB:
9.0
Source:
AGALSIDASE ALFA
3
Enzyme
Investigational
Unknown
Unknown
Fabry Disease
Globotriosylceramide
AGALSIDASE ALFA
×
Maximum Phase:
3
First Approval:
None
UNII:
2HLC17MX9G
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MECRYLATE
3
Small molecule
Investigational
Unknown
Unknown
Pilonidal Sinus; Wounds and Injuries
Unknown
MECRYLATE
×
Maximum Phase:
3
First Approval:
None
UNII:
WN7979561R
Molecule Type:
Small molecule
Molecular Formula:
C5H5NO2
Molecular Weight:
111.1
AlogP:
0.24
PSA:
50.09
HBD:
0.0
HBA:
#RotB:
1.0
Source:
IPA
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IPA
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALTROPANE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ALTROPANE
×
Maximum Phase:
3
First Approval:
None
UNII:
1Q4092099O
Molecule Type:
Small molecule
Molecular Formula:
C18H21FINO2
Molecular Weight:
429.27
AlogP:
3.88
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BOVINE HEPARIN
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOVINE HEPARIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GESTODENE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Progesterone receptor agonist
GESTODENE
×
Maximum Phase:
3
First Approval:
None
UNII:
1664P6E6MI
Molecule Type:
Small molecule
Molecular Formula:
C21H26O2
Molecular Weight:
310.44
AlogP:
3.66
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
RA-18C3
3
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RA-18C3
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMAZEPAM
3
Small molecule
Investigational
Unknown
Unknown
Dementia; Depressive Disorder; Schizophrenia; Anxiety
GABA receptor alpha-2 subunit positive allosteric modulator
BROMAZEPAM
×
Maximum Phase:
3
First Approval:
None
UNII:
X015L14V0O
Molecule Type:
Small molecule
Molecular Formula:
C14H10BrN3O
Molecular Weight:
316.16
AlogP:
2.63
PSA:
54.35
HBD:
1.0
HBA:
#RotB:
1.0
Source:
IDAZOXAN
3
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Depressive Disorder, Major
Adrenergic receptor alpha-2 antagonist
IDAZOXAN
×
Maximum Phase:
3
First Approval:
None
UNII:
Y310PA316B
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
0.83
PSA:
42.85
HBD:
1.0
HBA:
#RotB:
1.0
Source:
OPC-6535
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OPC-6535
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
×
Maximum Phase:
3
First Approval:
None
UNII:
LUY6P8763W
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OREGOVOMAB
3
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
Mucin-16 other
OREGOVOMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
HX101E7L6S
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABX-CBL
3
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ABX-CBL
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DONAPERMINOGENE SELTOPLASMID
3
Gene
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Myocardial Ischemia; Ischemia; Peripheral Arterial Disease; Diabetic Foot; Diabetic Neuropathies
Unknown
DONAPERMINOGENE SELTOPLASMID
×
Maximum Phase:
3
First Approval:
None
UNII:
5WL65F3KCB
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROCTOCOG ALFA PEGOL
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TUROCTOCOG ALFA PEGOL
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SACCHARIN
3
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Unknown
SACCHARIN
×
Maximum Phase:
3
First Approval:
None
UNII:
FST467XS7D
Molecule Type:
Small molecule
Molecular Formula:
C7H5NO3S
Molecular Weight:
183.19
AlogP:
0.12
PSA:
63.24
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARBOGEN
3
Unknown
Investigational
Unknown
Unknown
Seizures, Febrile; Ischemic Stroke; Urinary Bladder Neoplasms
Unknown
CARBOGEN
×
Maximum Phase:
3
First Approval:
None
UNII:
FJQ44KPA4J
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIFERMINOGENE PECAPLASMID
3
Gene
Investigational
Unknown
Unknown
Arterial Occlusive Diseases; Peripheral Arterial Disease; Peripheral Vascular Diseases
Unknown
RIFERMINOGENE PECAPLASMID
×
Maximum Phase:
3
First Approval:
None
UNII:
3G30P7ME1J
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDIUM-CHAIN TRIGLYCERIDES
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MEDIUM-CHAIN TRIGLYCERIDES
×
Maximum Phase:
3
First Approval:
None
UNII:
C9H2L21V7U
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDISAMIL
3
Small molecule
Investigational
Unknown
Unknown
Arrhythmias, Cardiac
Voltage-gated potassium channel blocker
TEDISAMIL
×
Maximum Phase:
3
First Approval:
None
UNII:
A5VAY2U3R8
Molecule Type:
Small molecule
Molecular Formula:
C19H32N2
Molecular Weight:
288.48
AlogP:
3.23
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PAFURAMIDINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PAFURAMIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
H1VG379J2X
Molecule Type:
Small molecule
Molecular Formula:
C20H20N4O3
Molecular Weight:
364.41
AlogP:
3.57
PSA:
103.36
HBD:
4.0
HBA:
#RotB:
6.0
Source:
VALNOCTAMIDE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VALNOCTAMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
3O25NRX9YG
Molecule Type:
Small molecule
Molecular Formula:
C8H17NO
Molecular Weight:
143.23
AlogP:
1.54
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ROCILETINIB
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
ROCILETINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
72AH61702G
Molecule Type:
Small molecule
Molecular Formula:
C27H28F3N7O3
Molecular Weight:
555.56
AlogP:
4.78
PSA:
111.72
HBD:
3.0
HBA:
#RotB:
8.0
Source:
FASINUMAB
3
Antibody
Investigational
Unknown
Unknown
Abdominal Pain; Back Pain; Low Back Pain; Osteoarthritis; Sciatica; Osteoarthritis, Hip; Osteoarthritis, Knee
Beta-nerve growth factor inhibitor
FASINUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
11T51Q3082
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIPLON
3
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Sleep Initiation and Maintenance Disorders
GABA receptor alpha-1 subunit positive allosteric modulator
INDIPLON
×
Maximum Phase:
3
First Approval:
None
UNII:
8BT63DA42E
Molecule Type:
Small molecule
Molecular Formula:
C20H16N4O2S
Molecular Weight:
376.44
AlogP:
3.67
PSA:
67.57
HBD:
0.0
HBA:
#RotB:
4.0
Source:
EBI-005
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
EBI-005
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LENOGRASTIM
3
Protein
Investigational
Unknown
Unknown
Myocardial Infarction; Prostatic Neoplasms, Castration-Resistant; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma
Granulocyte colony stimulating factor receptor agonist
LENOGRASTIM
×
Maximum Phase:
3
First Approval:
None
UNII:
6WS4C399GB
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONO-1101
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-1101
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMIPLACEL
3
Cell
Investigational
Unknown
Unknown
Hypertension, Pulmonary; Wounds and Injuries; Intermittent Claudication; Peripheral Arterial Disease; Severe Acute Respiratory Syndrome; Hip Fractures; Ischemia
Unknown
EMIPLACEL
×
Maximum Phase:
3
First Approval:
None
UNII:
DPX6XLD4X1
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
234
235
236
237
238
239
240
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA